Skip Content
You are currently on the new version of our website. Access the old version .

Livers, Volume 5, Issue 4

2025 December - 21 articles

Cover Story: This study analyzed tumor-associated macrophages (TAMs) in intrahepatic cholangiocarcinoma (ICC) using integrated RNA sequencing data. TAMs exhibited significant heterogeneity, co-expressing features of both inflammatory (M1) and anti-inflammatory (M2) macrophages, with specific markers like TREM2 and CD9 identified and validated. Immune profiling revealed a reduced M1/M2 macrophage ratio and an altered adaptive immune landscape, consistent with an immunotolerant tumor microenvironment. Protein network analysis pinpointed the TREM2-LGALS3 axis as a potential therapeutic target. The findings highlight TREM2-positive TAMs as a promising target for immunotherapy in ICC via the TREM2-LGALS3 pathway. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (21)

  • Article
  • Open Access
566 Views
19 Pages

Examining Vaccination Coverage in Patients with Diagnosis of Chronic Liver Disease and Cirrhosis: A Cross-Sectional Study in Greece

  • Paschalina Dafnou,
  • Ioannis Elefsiniotis,
  • Theodoula Adamakidou,
  • Nikoletta Margari,
  • Stelios Parissopoulos,
  • Lambrini Kourkouta,
  • Konstantinos Giakoumidakis and
  • Eleni Dokoutsidou

16 December 2025

Background/Objectives: Seasonal influenza, pneumococcal disease, and COVID-19 pose major public health challenges, particularly for individuals with chronic illnesses. This study examined vaccination coverage for influenza, pneumococcal disease, and...

  • Article
  • Open Access
457 Views
11 Pages

15 December 2025

Background: Methotrexate (MTX), a widely used therapeutic agent, is associated with hepatotoxicity. While cumulative MTX dosage has historically been linked to liver injury, recent evidence highlights the potential role of metabolic syndrome (MetS) a...

  • Protocol
  • Open Access
567 Views
15 Pages

Secondary Perfusion to Model Viability of Livers Declined for Transplantation

  • Avery K. Fortier,
  • Kimberly M. Feeney,
  • Matthew L. Holzner,
  • Joseph DiNorcia,
  • Ron Shapiro,
  • Leona Kim-Schluger,
  • Sander S. Florman,
  • L. Leonie van Leeuwen and
  • M. Zeeshan Akhtar

12 December 2025

Background/Objectives: The donor liver shortage has created an urgent need to utilize higher-risk grafts for transplantation. Normothermic machine perfusion enables ex vivo graft assessment prior to transplantation, offering a route to expand access...

  • Review
  • Open Access
981 Views
33 Pages

Implication of the Androgen Receptor in Muscle–Liver Crosstalk: An Overlooked Mechanistic Link in Lean-MASLD

  • Eleni Myrto Trifylli,
  • Christiana Charalambous,
  • Nikolaos Spiliotopoulos,
  • Nikolaos Papadopoulos,
  • Anastasia Oikonomou,
  • Spilios Manolakopoulos and
  • Melanie Deutsch

8 December 2025

Androgen receptor (AR) signaling has a pivotal role in hepatic lipid homeostasis, as well as in core metabolic functions such as lipogenesis, fatty acid oxidation, and insulin sensitivity. Dysregulation of AR function has been demonstrated in both an...

  • Review
  • Open Access
745 Views
16 Pages

Transplant vs. Resection for Non-HCC Malignancies of the Liver

  • Sibi Krishna Thiyagarajan,
  • Arielle Jacover,
  • Alfredo Verastegui,
  • Katherine Poruk and
  • John A. Stauffer

5 December 2025

Background: Surgical resection (SR) and liver transplantation (LT) are the main curative options for non-hepatocellular carcinoma (non-HCC) liver malignancies, including colorectal liver metastases (CRLMs), intrahepatic cholangiocarcinoma (iCCA), hil...

  • Article
  • Open Access
684 Views
34 Pages

5 December 2025

Background: Liver fibrosis is a progressive pathological condition characterized by excessive extracellular matrix deposition, driven by activated hepatic stellate cells (aHSCs). Effective therapeutic strategies require targeting aHSCs and agents cap...

  • Article
  • Open Access
1,658 Views
23 Pages

1 December 2025

Background: Intratumour heterogeneity (ITH) is one of the key characteristics of cancer and is closely associated with patient prognosis, treatment resistance, and tumor metastasis. Nevertheless, the study of ITH in hepatocellular carcinoma (HCC) rem...

  • Article
  • Open Access
634 Views
14 Pages

Gender Differences in Healthy Eating Index as Informed by the Awareness of Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease

  • Wei-Ting Lin,
  • Madeline Novack,
  • Suthat Liangpunsakul,
  • Chiung-Kuei Huang,
  • Hui-Yi Lin,
  • Po-Hung Chen,
  • Tung-Sung Tseng and
  • Peng-Sheng Ting

28 November 2025

Background/Objectives: Dietary quality is a driver of metabolic dysfunction-associated steatotic liver disease (MASLD). Men and women often have different levels of adherence to medical advice, but the effect of gender on adherence to dietary advice...

  • Systematic Review
  • Open Access
980 Views
24 Pages

Socioeconomic Disparities Along the Cancer Continuum for Hepatocellular Carcinoma: A Systematic Review

  • Justin Ong,
  • Vivian H. LeTran,
  • Christopher Wong,
  • Jonathan Tchan,
  • Selena Zhou,
  • Ariana Chen and
  • Kali Zhou

18 November 2025

Background: Social determinants of health critically impact outcomes along the care continuum of patients with hepatocellular carcinoma (HCC). This systematic review summarizes the effect of socioeconomic status (SES) factors on HCC outcomes in the U...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Livers - ISSN 2673-4389